Background High glucose (HG) induces production of transforming growth factor-beta1 (TGF-b1), but the mechanism remains elusive. The aim of this study was to determine the gene(s) involved in HG-induced TGF-b1 production in human peritoneal mesothelial cells (HPMCs). Methods Microarray analysis was performed following a 3-h preincubation of HPMCs in 4 or 0.1 % glucose medium. Transcriptional genes were selected using Gene Ontology analysis for biological processes, including regulation of transcription and DNA-dependent. The effects of small interfering RNA (siRNA) treatments on the up-regulation of TGF-b1 mRNA were assessed by quantitative real-time polymerase chain reaction (qPCR). Finally, enzyme-linked immunosorbent assay (ELISA) was performed to determine which gene(s) contribute to the production of TGF-b1 protein in the medium. Results Microarray analysis revealed that the expression of 51 genes increased by more than 3-fold. Gene ontology analysis identified 13 genes for further study. qPCR confirmed mRNA amplification for 9 of the 13 genes. Furthermore, HG-induced up-regulation of TGF-b1 mRNA was attenuated by the siRNA of 4 genes: MDS1 and EVI1 complex locus (MECOM), FBJ murine osteosarcoma viral oncogene homolog B (FOSB), FBJ murine osteosarcoma viral oncogene homolog (FOS) and activating transcription factor 3 (ATF3). ELISA showed that siRNA treatment of FOS, but not MECOM, FOSB or ATF3, suppressed the increase of TGF-b1 protein in the medium. Conclusions FOS is a downstream effector of HG stimulation in HPMCs that contributes to TGF-b1 production, suggesting that blocking FOS expression may be a therapeutic target for peritoneal fibrosis.
Introduction
Peritoneal mesothelial cells (PMCs) help maintain peritoneal homeostasis [1] . However, PMCs can be damaged by bio-incompatible materials in peritoneal dialysis (PD) fluid. Pathologically, persistent peritoneal damage by PD solution can lead to submesothelial fibrosis, which is characterized by denudation of PMCs from the peritoneum, excessive deposition of extracellular matrix, and neoangiogenesis. These structural alterations not only increase small-solute transport rates and ultrafiltration dysfunction, but also induce development of encapsulating peritoneal sclerosis [2] . Because PD solution directly exerts an influence on PMCs, biological changes of PMCs are likely to contribute to the development of peritoneal fibrosis and be a promising therapeutic target. However, a clinical treatment for peritoneal fibrosis has not yet been established.
Glucose is used as an osmotic agent in PD solution, but glucose-based solutions are associated with increased inflammatory cytokines. Glucose-mediated production of transforming growth factor-beta1 (TGF-b1) plays a pivotal role in the progression of peritoneal fibrosis by inducing numerous pro-fibrotic events such as the epithelial-tomesenchymal transition (EMT), proliferation of fibroblasts and deposition of extracellular matrix protein [3] . Although high glucose (HG) is a known inducer of TGF-b1 production, the exact pathway remains elusive. Moreover, previous studies have demonstrated that the expression of TGF-b1 mRNA was increased after 24 h of HG treatment, but not before 24 h, indicating that two or more transcriptional factors are implicated in the expression of TGFb1 [4] [5] [6] . The aim of this study is to determine the gene(s) involved in HG-induced TGF-b1 production in human peritoneal mesothelial cells (HPMCs) .
In this study, we used data obtained from a gene expression array and subsequent Gene Ontology analysis for biological processes, to identify candidate genes involved in HG-induced TGF-b1 production. Following confirmation of elevated mRNA levels via quantitative real-time polymerase chain reaction (qPCR), knockdown studies using small interference RNA (siRNA) for each candidate were performed to examine the effect on TGF-b1 production. Enzyme-linked immunosorbent assays (ELISA) revealed that knockdown of FBJ murine osteosarcoma viral oncogene homolog (FOS), also called ''c-fos'', suppresses the increase of TGF-b1 protein in the medium. In addition, immunohistochemical staining revealed that HG injection into mice peritoneal cavity resulted in a significant increase in FOS expression as well as TGF-b1 up-regulation. Our findings demonstrate that FOS is a downstream effector of HG stimulation in HPMCs, which contributes to TGF-b1 production.
Methods

Cell cultures
Human peritoneal mesothelial cells were isolated from human omentum as described previously [7] . Harvesting of the omentum was permitted by the Medical Ethics Committee of Hiroshima Graduate School of Biomedical Sciences and informed consent was obtained from each patient. HPMCs from the second to third passages were used. Standard M199 medium (Life Technologies, NY, USA) containing 10 % fetal calf serum (FCS; volume/ volume; Thermo Fisher Scientific, MA, USA), 100 U/mL penicillin, 100 lg/mL streptomycin (Nacalai Tesque, Tokyo, Japan) and 2 mmol/L L-glutamine (Life Technologies, Grand Island, NY, USA) was used as the control (glucose concentration = 0.1 %: ''normal glucose'': NG). In the experimental cultures, the control medium was supplemented with D-glucose (Sigma-Aldrich, St Louis, MO, USA), and the glucose concentration was increased to 4 % (glucose concentration = 4 %: ''high glucose'': HG). All culture media were sterilized by filtration and then stored at 4°C for use within 2 days. HPMCs were seeded into 6-well plates and grown to subconfluence; the culture media were then replaced with NG or HG for 1-48 h.
Gene expression analysis
Human peritoneal mesothelial cells isolated from three donors were incubated in NG or HG for 3 h, and total RNA was extracted using Qiagen RNeasy kit. Total RNA was treated with DNase to remove any residual genomic DNA and then gene expression profiling between the 2 groups was compared using GeneChip Human Genome U133 Plus 2.0 Expression arrays (Affymetrix, Inc., Tokyo, Japan). The Affymetrix Human Genome U133 Plus 2.0 microarray chip comprises about 47,000 transcripts and about 54,000 probe sets. Raw intensity values were normalized and logtransformed using GeneSpring GX 10 software (Agilent Technologies, CA, USA).
Analysis of mRNA levels
RNA extraction and qPCR were performed as previously described [8] . Specific oligonucleotide primers and probes for TGF-b1 (assay ID: Hs99999918_m1), SIX homeobox 4 (SIX4) (assay ID:Hs00213614_m1), transducin-like enhancer of split 4 (TLE4) (assay ID:Hs00419101_m1), nuclear receptor subfamily 4, group A, member 2 (NR4A2) (assay ID:Hs004286991_m1), chromosome 5 open reading frame 41 (C5orf41) (assay ID:Hs01078210_m1), zinc finger and BTB domain containing 1 (ZBTB1) (assay ID:Hs01040451_m1), cysteine-serine-rich nuclear protein 1 (CSRNP1) (assay ID:Hs01042624_m1), and 18S rRNA (endogenous control) were obtained as TaqMan Gene Expression Assays (Applied Biosystems, Foster City, CA, USA).
The sequences of the primers for human MDS1 and EVI1 complex locus (MECOM), early growth response 1 (EGR1), FBJ murine osteosarcoma viral oncogene homolog B (FOSB), SIX homeobox 1 (SIX1), FOS, Kruppellike factor 5 (KLF5), and activating transcription factor 3 (ATF3) were designed according to the ProbeFinder TM software of Roche Universal Probe Library system (Roche Applied Science). Table 1 provides detailed information on primer sequences. The mRNA levels were normalized for 18S rRNA levels.
siRNA transfection
When the HPMCs were grown to 50 % confluence in 6--well plates, the transient transfection was performed with specific stealth siRNA against a target gene, or Silencer Negative Control #1 siRNA using Lipofectamine 2000 (Invitrogen; Carlsbad, California, USA), according to the manufacturer's instructions. After 24 h, the medium was changed to M199 medium containing 10 % FCS. When the HPMCs were grown to 80 % confluence, glucose stimulation was started. The effect of the target gene knockdown was examined using qPCR following 3 h of stimulation. Cells were cultured in NG or HG media for 3 and 24 h to detect the mRNA expression by qPCR and for 48 h to measure protein by ELISA.
ELISA
Cultures of HPMC were grown in 6-well plates at NG or HG medium for 24 and 48 h. At the end of the incubation period, supernatants were collected and cell lysates were extracted using cell lysis buffer (Cell Signaling Technology, Beverly, MA, USA) to determine the protein content. The concentrations of TGF-b1 in the culture supernatant were measured with ELISA (R&D Systems, Minneapolis, MN, USA), following the manufacturer's instructions. The protein concentration of cell lysates was determined by the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA). The ELISA results were corrected for total protein content.
Western blot analysis
The expression levels of FOS protein were examined by Western blot analysis. Sample collection and immunoblotting were performed as previously described [8] . Primary antibodies used in this study were rabbit polyclonal anti-c-Fos antibody (Cell Signaling Technology) and rabbit polyclonal anti-Actin antibody (Sigma-Aldrich) at dilutions of 1:500 and 1:200, respectively. The secondary antibody used in this study was horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (Dako, Glostrup, Denmark). Signals were detected using the SuperSignal West Dura or Pico system (Thermo Fisher, Rockford, IL, USA). The intensity of each band was determined using ImageJ software (version 1.45; National Institutes of Health, Bethesda, MD, USA).
Animals
Animals used in this study were male C57BL/6 mice at 12 weeks of age. Mice were divided into three groups (n = 5 per group) and 2 ml of phosphate-buffered saline (PBS) composed of 4 % glucose or 4 % D-mannitol (approximately 500 mOsm/kg: the same osmolality as 4 % glucose; Wako Pure Chemical Industries, Ltd, Osaka, Japan) or PBS only was administered into the peritoneal cavity twice a day for 1 week. Parietal peritoneum samples were obtained from the contralateral side of injection. All the animal experiments were approved by the Institutional Animal Care and Use Committee of Hiroshima University (Hiroshima, Japan) and were performed in accordance with the National Institutes of Health Guidelines on the Use of Laboratory Animals.
Histology and immunohistochemistry
Histology and immunohistochemical staining of 4-lmthick tissue sections were performed as described previously [9] . The following primary antibodies were used: rabbit polyclonal anti-FOS antibody (Sigma-Aldrich); rabbit polyclonal anti-TGF-b1 antibody (Sigma-Aldrich). The positive areas of FOS and TGF-b1 were assessed in predetermined fields (9400) of the mesothelial cells captured by a digital camera and the area stained was determined using ImageJ software in 5 fields.
Statistical analysis
The results were expressed as mean ± SD. Statistical analyses were performed using analysis of variance followed by Tukey's post hoc test or the Student's t test. A value of P \ 0.05 was considered to be statistically significant.
Results
Effect of HG on TGF-b1 production in HPMCs
We examined HG-induced synthesis of TGF-b1 in HPMCs. TGF-b1 mRNA levels did not change over the first 12 h, but had significantly increased by 24 h compared with pre-stimulation levels (Fig. 1a) . Protein levels of TGF-b1 in the culture supernatant were similar at 24 h, but increased 1.4-fold at 48 h in cells incubated in HG compared with NG (Fig. 1b) .
HG-stimulated up-regulation of transcriptional genes in HPMCs
To identify genes involved in the regulation of TGF-b1 production by HG stimulation, we performed DNA microarray analysis using HPMCs obtained from three patients and treated in NG or HG medium for 3 h. Genes were selected using a 3-fold increase as the threshold [10] . Fifty-one up-regulated genes in the HG group were amplified at least 3-fold more than in the NG group. Among these, we focused on genes encoding transcription factors. We selected 13/51 genes using criteria such as ''regulation of transcription'' and ''DNA-dependent'' for Gene Ontology analysis (Table 2) .
HG-induced actual increase of mRNA expression in HPMCs
To validate the microarray results, we carried out qPCR of the selected genes. mRNA expression levels of 9 genes (MECOM, EGR1, FOSB, NR4A2, FOS, C5orf41, KLF5, CSRNP1, and ATF3) were confirmed to increase in HPMCs treated by HG for 3 h (Fig. 2a) . The mRNA expression of SIX4, TLE4, SIX1, and ZBTB1 did not increase more than 3 times (Fig. 2b) .
Inhibitory effect of siRNA on HG-induced TGF-b1 mRNA up-regulation in HPMCs
To assess the contribution to TGF-b1 production, we investigated the effects of RNA interference for the 9 genes on TGF-b1 mRNA expression. MECOM siRNA significantly reduced MECOM mRNA (mean % reduction compared to the negative control = 87 %, n = 3 
Effect of siRNA on HG-induced TGF-b1 protein upregulation of HPMCs
To investigate the effect of MECOM, FOSB, FOS and ATF3 on TGF-b1 protein expression, we performed ELISA to measure the concentration of TGF-b1 protein in the supernatant of cultured HPMCs with or without siRNA treatment for the 4 genes. TGF-b1 protein in the normal M199 medium containing 10 % FCS was measured in advance and then the amount of change was compared. Among the 4 genes, siRNA treatment showed that the concentration of TGF-b1 protein in the supernatant was reduced only by the FOS-siRNA treatment (Fig. 4) .
HG induced the expression of FOS mRNA and protein in HPMCs
Temporal changes of FOS mRNA expression and protein stimulated in HG medium of HPMCs were indicated by qPCR and Western blot analysis. The levels of FOS mRNA increased more than 22-fold at 3 h, and after that decreased and returned to pre-stimulation levels at 24 h (Fig. 5a) . When HPMCs were cultured in HG medium, FOS protein began to increase after 2 h, peaked at 3 h, and then decreased substantially (Fig. 5b) . In addition, we determined that FOS protein was strongly suppressed by siRNA treatment after 3 h under HG conditions (Fig. 5c) .
Effect of HG on mouse peritoneal membrane
We examined the peritoneal expression of FOS and TGFb1 after the intraperitoneal administration of HG in mice. Mannitol was also injected as an osmotic control. There were no differences between groups in appearance and hematoxylin-eosin staining (Fig. 6a) . Both FOS and TGFb1 expression were observed in the cytoplasm of mesothelial cells (Fig. 6b, c) . FOS expression in the mesothelial cells of HG-injected mice was 2.0-fold higher than levels in the vehicle group, while mannitol injection led to a 1.3-fold increase (Fig. 6d) . Similarly, TGF-b1 increased 2.4-fold in the HG group and 1.4-fold in the mannitol group relative to the vehicle group (Fig. 6e) . Although mannitol induced the expression of both FOS and TGF-b1, these effects were significantly lower than those produced by exposure to glucose.
Discussion
The data presented here show that HG-induced upregulation of TGF-b1 is mediated by FOS expression, and that other genes are not likely linked to TGF-b1 production in HPMCs. We also observed that FOS and TGF-b1 are upregulated by HG injection into the peritoneal cavity in mice. FOS is known as a major component of activator protein-1 (AP-1) complex, indicating that AP-1 plays a critical role in TGF-b1 induction and that blocking FOS expression may be a therapeutic target for peritoneal fibrosis.
Ha and Lee have demonstrated that HG-induced reactive oxygen species (ROS) leads to synthesis of TGF-b1 mRNA and protein in HPMCs [11] . A previous study has described that HG induces a dynamic change in mitochondrial morphology, which is required to increase the early production of ROS [12] . Importantly, a past study has demonstrated that 3-O-methyl glucose, a non-metabolizable glucose analog, did not induce ROS generation [11] . It has also been reported that a glucose transporter inhibitor abolished HGinduced ROS generation [13] . These findings indicate that the up-regulation of TGF-b1 synthesis is caused by glucose uptake, but not high osmolality. Because we identified only FOS as a responsible gene for HG-induced TGF-b1 production, HG-induced ROS might be involved in increased TGF-b1 expression through FOS up-regulation. Wei et al. have reported that glucose metabolism participates in HG-induced ROS generation, resulting in enhancing extracellular signal-regulated kinase (ERK) pathways [14] . Several studies have also demonstrated that the expression of FOS is regulated by mitogen-activated protein kinase (MAPK) pathways in various cells [15, 16] . Our previous study also shows that ERK phosphorylation increases in response to HG and peaks at 30 min in HPMCs [17] . Notably, Yokoyama et al. have revealed that inhibition of ERK1/2 significantly inhibited the induction of FOS expression [18] , indicating that ERK activation is the upstream effector of FOS expression. These results raise the possibility that HG-induced ROS up-regulates FOS expression via ERK activation.
It has been reported that HG increases intracellular diacylglycerol (DAG) levels, leading to protein kinase C (PKC) activation [19] , which stimulates FOS gene expression [18] . However, our data show that FOS mRNA and protein peaked at 3 h, whereas Ha et al. have revealed that HG-induced up-regulation of [ 3 H] DAG levels and PKC activity are observed after 8 h [19] . Activation of PKC is reportedly involved in increasing transcriptional activity and increasing stabilization of mRNA [20] . Therefore, PKC is not likely to contribute to HG-induced FOS expression in the early phase, but may participate in TGF-b1 production. Among a number of transcriptional factors, upstream stimulatory factors 1 and 2 (USF1 and 2) [4] , nuclear factor (NF)-jB [5] , AP-1, and stimulating protein 1 (Sp1) [6] reportedly contribute to the regulation of TGF-b1. In this study, we found that only FOS mediates between HG and TGF-b1 in HPMCs, thereby suggesting Ap-1 as a transcriptional factor contributing to HG-induced TGF-b1 production. AP-1 is a dimeric transcription factor comprising proteins from several families whose common denominator is the possession of basic leucine zipper domains, which are essential for dimerization and DNA binding. The human TGF-b1 promoter region contains two binding sequences for AP-1, designated AP-1 box A (TGACTCT) and box B (TGTCTCA), which mediate the up-regulation of promoter activity after HG stimulation. It has also been reported that HG markedly increases the binding activity of nuclear AP-1 proteins in mesangial cells in box B [6] . These findings imply that HG not only induces FOS production, but also increases binding and promoter activities.
We did not detect the up-regulation of the other components of AP-1, including JUN, ATF, and Maf families [18] . Importantly, FOS, but not JUND or Fra-2, plays a critical role in binding the proximal AP-1 site of the TGFb1 promoter [21] , suggesting that FOS induction by HG plays a pivotal role in TGF-b1 production. Furthermore, FOS is not only required for TGF-b1 production, but also for various gene products, including Bcl-2, cyclin D1, cdc2, Cox-2, vascular endothelial growth factor, matrix metalloproteinases, and vimentin. Therefore, AP-1 has numerous downstream effects on many cellular processes including proliferation, survival, differentiation, apoptosis, cell migration, and transformation [22] [23] [24] , implying that blocking transcription of AP-1 by inhibiting FOS expression may be a therapeutic target for peritoneal fibrosis. In the present study, HPMCs were incubated in 4 % glucose medium for 3 h, followed by microarray analysis. Fifty-one genes displayed an increase of more than 3-fold compared to control. Thirteen genes (SIX4, MECOM, EGR1, FOSB, TLE4, SIX1, NR4A2, FOS, C5orf41, KLF5, ZBTB1, CSRNP1, ATF3) were identified as relevant to Immunohistochemical analyses of (b) FOS and c TGF-b1 expression in peritoneal tissues. (original magnification 9400). d, e The numbers of FOS and TGF-b1-positive pixels were measured. (mean ± SD, n = 5, *P \ 0.05, **P \ 0.001) biological processes, including the regulation of transcription, and being DNA dependent in the Gene Ontology category. As a result of qPCR, 9 mRNA products (MECOM, EGR1, FOSB, NR4A2, FOS, C5orf41, KLF5, CSRNP1, ATF3) were confirmed as amplified in HG. Subsequently, TGF-b1 mRNA was attenuated by siRNAs of 4 genes (MECOM, FOSB, FOS, ATF3). Lastly, treatment with FOS-siRNA specifically reduces the increase of TGF-b1 protein by HG stimulation. Because siRNA for MECOM, FOSB, and ATF3 suppressed high glucose-induced TGF-b1 mRNA levels, but not TGF-b1protein levels, the knockdown effects of these genes on TGF-b1 suppression are thought to be lower than the impact of FOS. In conclusion, we identified FOS as a gene responsible for TGF-b1 production in HPMCs and suggest that it may play a central role in the development of peritoneal fibrosis.
